Marijuana Stocks To Buy The First Week Of January?
2023 has officially begun for marijuana stock investors. This upcoming week there is a good amount of anticipation. Many people throughout the sector will be watching marijuana stocks closely. It’s not so much that investors feel that the action will change but this past year showed people how to adapt in volatile markets. Most marijuana stocks trade in an unpredictable fashion most times. Yet unless there is a reason for a company to see a rise in trading. For example, a company can produce strong earnings or release news that is big enough to see an upward push in trading.
So with investors having a better idea of how marijuana stocks trade being able to see better profits could be easier. To be clear investors know that marijuana stocks have turned into a buy-and-hold game over the last year. So when a decline would take place this was time to find marijuana stocks to buy.
Once the buying time was over and things began to recover oftentimes the rise was not on the same trading day. Nevertheless this year we will see several catalysts that could help the overall trading in the cannabis sector. Just make sure to do your research and follow the trends in the cannabis industry to have better insight. The companies below are a few marijuana stocks to watch in 2023.
Top Marijuana Stocks to Watch
Organigram Holdings Inc.
Organigram Holdings Inc. through its subsidiaries engages in the production and sale of cannabis and cannabis-derived products in Canada. The company announced it won the KIND magazines cannabis company of the year award.
Along with the most innovative product of the year for Edison JOLTS. KIND’s marquee award, Cannabis Company of the Year is presented to the licensed producer that the KIND editorial team believes demonstrates the best combination of people, purpose and product in a given year.
Words From The Company
“We are very proud to be recognized by KIND Magazine,” says Beena Goldenberg, CEO, Organigram. “The Cannabis Company of the Year award is particularly special because it not only acknowledges Organigram as a top performing licensed producer, but also celebrates the high-quality of our talented employees from coast-to-coast. Likewise, the award is unique as it considers ‘purpose’, recognizing Organigram’s commitment to doing good in the communities we serve.”
TerrAscend Corp. cultivates, processes, and sells medical and adult-use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations. Plus manufactures cannabis-infused artisan edibles.
The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. On December 21st the company released an amendment news release. The news is TerrAscend announced an amendment to the Pennsylvania credit agreement.
Highlights Of The Agreement
- Amendment will reduce Company debt by $35 million and annual interest expense by $5 million
- Combined with recently announced debt retirement of $125 million, Company debt will be
- reduced by a cumulative $160 million and will result in total annual interest savings of $15
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | firstname.lastname@example.org